chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Magnetic resonance imaging thoracic normal, Muscular weakness, Rheumatoid factor negative
Clinical narrative: Pt seen initially 6 months after vaccination with complaint of worsening generalized anxiety disorder, fatigue and 70-80lb unintentional weight loss with 40lbs occurring in 3m prior to our first visit. At that time pt was started on SSRI for anxiety and labs were ordered for w/u of unintentional weight loss. found to have persistent leukocytosis. had work up for chronic infection, leukemia/lymphoma which were all negative. pt was evaluated by heme/onc without definitive dx. Pt's anxiety improved somewhat with tx however she developed weakness in R > L leg and b/l forearms. Had additional w/u by neurology and was told that her symptoms were likely related to moderna vaccine
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory disturbance, White blood cell count increased
Clinical narrative: Pt seen initially 6 months after vaccination with complaint of worsening generalized anxiety disorder, fatigue and 70-80lb unintentional weight loss with 40lbs occurring in 3m prior to our first visit. At that time pt was started on SSRI for anxiety and labs were ordered for w/u of unintentional weight loss. found to have persistent leukocytosis. had work up for chronic infection, leukemia/lymphoma which were all negative. pt was evaluated by heme/onc without definitive dx. Pt's anxiety improved somewhat with tx however she developed weakness in R > L leg and b/l forearms. Had additional w/u by neurology and was told that her symptoms were likely related to moderna vaccine
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaccination site rash, Vaccination site urticaria
Clinical narrative: rash/hives at site of immunization and below waist not itching
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Brain scan normal, Laboratory test normal, Tinnitus
Clinical narrative: Approximately after two weeks after the first dose of the vaccine, I developed Tinnitus in both ears. I saw my Primary Dr. who referred me to the EMT Dr. who did a number of test and then referred my to a neurologist and she also did a number of test and the result was that all test were negative, and the Dr. felt that my Tinnitus was caused by the vaccine.  She said that she had seen and evaluated a number of patients with the same experience.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bronchitis, Chest discomfort, Chills, Computerised tomogram, Cough
Clinical narrative: I experienced upper respiratory tightness, diarrhea, chills, wheezing, cough, bronchitis and fever.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Pyrexia, Wheezing
Clinical narrative: I experienced upper respiratory tightness, diarrhea, chills, wheezing, cough, bronchitis and fever.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary arterial stent insertion, Coronary artery occlusion, Myocardial infarction
Clinical narrative: Heart attack, 100 % blockage in artery, stent implant required. Class 1 FAA medical give every 6 months for over 10 years and no limitations. No history of heart desease or high blood pressure.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: patient experienced hives all over body
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation, General physical health deterioration
Clinical narrative: 8/10/22 pt brought to ED from nursing home via EMS for hypoxia; O2 saturations in the 70s; intubated; hypothermic and hypotensive; given vasopressors; recent hospitalization on 7/13/22 for UTI and COVID infection and COVID pneumonia; treated with Rocephin; code stroke called; pt's condition deteriorated and she passed away in the hospital
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Hypothermia, Hypoxia, Urinary tract infection
Clinical narrative: 8/10/22 pt brought to ED from nursing home via EMS for hypoxia; O2 saturations in the 70s; intubated; hypothermic and hypotensive; given vasopressors; recent hospitalization on 7/13/22 for UTI and COVID infection and COVID pneumonia; treated with Rocephin; code stroke called; pt's condition deteriorated and she passed away in the hospital
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: was given with Bivalent Maroon Cap before completing the primary series / patient's second dose; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team.  A 3-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Dec2022 as dose 2 (maroon cap), 0.2 ml single (Lot number: GK1667, Expiration Date: 03Jul2023) at the age of 3 years intramuscular, in left thigh for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for COVID-19 immunization. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 31Dec2022, outcome "unknown", described as "was given with Bivalent Maroon Cap before completing the primary series / patient's second dose". Additional information: The patient was 3 years, 7 months old. The patient was given with Bivalent Maroon Cap before completing the primary series. This was the patient's second dose, instead of giving the monovalent maroon cap as stated. Stated that this was a medication error. Had no issues that reporter was aware of at this point so would say that patient recovered completely. No treatment was given. The reporter was asking if they needed to give another bivalent vaccine for the third dose and for the recommendations. Event was reported as medically significant by the reporter. Vaccine was administered in the anterior lateral thigh on the left side.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Antibody test, COVID-19, Computerised tomogram, Drug ineffective
Clinical narrative: had covid twice and been getting sick a lot./She woke up with fever; had covid twice and been getting sick a lot.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent.  A 7-year-old female patient received BNT162b2 (BNT162B2), as dose 1 (orange cap), single (Batch/Lot number: unknown) and as dose 2 (orange cap), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "had covid twice and been getting sick a lot./She woke up with fever"; COVID-19 (medically significant), outcome "unknown", described as "had covid twice and been getting sick a lot.". The patient underwent the following laboratory tests and procedures: Allergy test: negative, notes: negative for mold, cats & dogs, wheat and weeds and all that." The results showed she has no allergies; Antibody test: no antibodies to streptococcal pneumoniae,, notes: no antibodies to streptococcal pneumoniae, 23 serotypes; antibodies, notes: IGG, IGA are present, but some are not present , some are extremely low and some are normal; Computerised tomogram: enlarged lymph nodes in her abdominal region, notes: enlarged lymph nodes in her abdominal region; Full blood count: Not immune to Chicken pox, notes: Not immune to Chicken pox, (varicella antibodies) no antibodies to streptococcal pneumoniae, 23 serotypes; Red blood cell count: elevated, notes: elevated; SARS-CoV-2 test: Positive; White blood cell count: low, notes: low; normal, notes: was normal but on the higher range of normal.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events drug ineffective, covid-19 and syncope with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202300004133 Same patient/vaccine, different dose;US-PFIZER INC-202300003782 same patient, different dose vaccine and event;
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Red blood cell count, SARS-CoV-2 test, White blood cell count
Clinical narrative: had covid twice and been getting sick a lot./She woke up with fever; had covid twice and been getting sick a lot.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent.  A 7-year-old female patient received BNT162b2 (BNT162B2), as dose 1 (orange cap), single (Batch/Lot number: unknown) and as dose 2 (orange cap), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "had covid twice and been getting sick a lot./She woke up with fever"; COVID-19 (medically significant), outcome "unknown", described as "had covid twice and been getting sick a lot.". The patient underwent the following laboratory tests and procedures: Allergy test: negative, notes: negative for mold, cats & dogs, wheat and weeds and all that." The results showed she has no allergies; Antibody test: no antibodies to streptococcal pneumoniae,, notes: no antibodies to streptococcal pneumoniae, 23 serotypes; antibodies, notes: IGG, IGA are present, but some are not present , some are extremely low and some are normal; Computerised tomogram: enlarged lymph nodes in her abdominal region, notes: enlarged lymph nodes in her abdominal region; Full blood count: Not immune to Chicken pox, notes: Not immune to Chicken pox, (varicella antibodies) no antibodies to streptococcal pneumoniae, 23 serotypes; Red blood cell count: elevated, notes: elevated; SARS-CoV-2 test: Positive; White blood cell count: low, notes: low; normal, notes: was normal but on the higher range of normal.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events drug ineffective, covid-19 and syncope with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202300004133 Same patient/vaccine, different dose;US-PFIZER INC-202300003782 same patient, different dose vaccine and event;
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: getting more sick; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent.  A 7-year-old female patient received BNT162b2 (BNT162B2), in 2022 as dose 1 (orange cap), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 2022, outcome "unknown", described as "getting more sick". Additional information: Patient got her first dose in the primary series with the monovalent orange cap 5-11 formulation of the Pfizer BioNTech Covid 19 vaccine last year. Since then she's been sick various things, she has been getting more sick especially after having the second shot of the vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300003701 same patient, different dose vaccine and event;US-PFIZER INC-202300004133 same patient, different dose vaccine and event;
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: got covid after 3 vaccinations and still got long haul covid; got covid after 3 vaccinations and still got long haul covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Fever", start date: Jan2022 (unspecified if ongoing), notes: I have had a fever everyday since January last year. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "got covid after 3 vaccinations and still got long haul covid".  Clinical course: patient was seeking assistance with the medication Prempro. Patient reported had not worked in over a year because had been diagnosed with long haul Covid, and also been diagnosed with fibromyalgia and chronic fatigue syndrome and do not even drive, had got a lot of health issues going on. Patient even got covid after 3 vaccinations and still got long haul covid and have had a fever everyday since January last year. Patient had to have surgery to remove ovaries and everything at 38 years old, and that was not including a double mastectomy after that.  The information on the batch/lot number for COVID-19 Vaccine - Manufacturer Unknown has been requested and will be submitted if and when received.
Age: 33.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: COVID-19, Malaise, Product storage error, SARS-CoV-2 test positive
Clinical narrative: I received a covid booster at this pharmacy on 10/1/22. I received a positive covid test on 12/14/22. On 12/20/22 I was contacted by pharmacy that a "temperature excursion" had occurred, compromising my vaccine. This was 6 days after the positive test, at which time I was experiencing severe symptoms that reflected that I was in effect un-boosted. The notification to me came 80 days after the booster was administered. I am submitting this report to document that my booster was not maintained at the right temperature and that it took 80 days to notify me, by which time, as I mentioned, I was quite sick over the Christmastime holidays (symptoms have not fully cleared up after 3 weeks).
Age: 33.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Product storage error
Clinical narrative: I received a covid booster at this pharmacy on 10/1/22. I received a positive covid test on 12/14/22. On 12/20/22 I was contacted by pharmacy that a "temperature excursion" had occurred, compromising my vaccine. This was 6 days after the positive test, at which time I was experiencing severe symptoms that reflected that I was in effect un-boosted. The notification to me came 80 days after the booster was administered. I am submitting this report to document that my booster was not maintained at the right temperature and that it took 80 days to notify me, by which time, as I mentioned, I was quite sick over the Christmastime holidays (symptoms have not fully cleared up after 3 weeks).
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Periarthritis
Clinical narrative: severe shoulder pain thereafter.  Developed clinically SEVERE Adhesive Capsulitis, still unresolved.  Cannot abduct arm past 25 degrees
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test normal, Nausea, Parosmia, Vomiting
Clinical narrative: Have started to constantly smell cigarettes; The smell has led to me being nauseous and vomiting; My doctor drew a blood panel but didn't find any cause.
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: The patient received the Pfizer bivalent booster vaccine but had never received any doses of a primary series. No adverse events were reported.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: admit for SOB
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Bone disorder, Contusion, Magnetic resonance imaging
Clinical narrative: 1st Pfizer dose 2/28/21 EL9266 , 2nd dose 3/16/21 EN6206 both at site for Hospital. On 6/18/21 me and my family noticed circle bruises all over both of my arms and they were hurting me so I went to Hospital Emergency Room. I have those records in Chart . The Dr's couldn't understand why I was bruising in perfect circles and they watched bruising appear on my arms. July 12, 2021 I was referred to a specialist but by that time they was gone. On 1/19/22 I had my 3rd dose FD7218 @ nursing home. I went to the Dr on 4/2022 with wrist pain, 6/2022 with wrist pain and in August 2022 they defray and found Keinbocks disease of my right wrist. No Blood flow to lunate bone.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, X-ray
Clinical narrative: 1st Pfizer dose 2/28/21 EL9266 , 2nd dose 3/16/21 EN6206 both at site for Hospital. On 6/18/21 me and my family noticed circle bruises all over both of my arms and they were hurting me so I went to Hospital Emergency Room. I have those records in Chart . The Dr's couldn't understand why I was bruising in perfect circles and they watched bruising appear on my arms. July 12, 2021 I was referred to a specialist but by that time they was gone. On 1/19/22 I had my 3rd dose FD7218 @ nursing home. I went to the Dr on 4/2022 with wrist pain, 6/2022 with wrist pain and in August 2022 they defray and found Keinbocks disease of my right wrist. No Blood flow to lunate bone.
Age: 1.0
Sex: F
Vaccine: MMRV, PNC13
Symptoms: Rash, Urticaria
Clinical narrative: Patient received Proquad vaccine on 9/26. On 9/27 patient broke out in rash and was told to go to the ED. Patient was given steriods to take at home and was given dexamethasone at the hospital. Patient was seen at office four days later and was diagnosed with urticaria.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anti-thyroid antibody, Anxiety, Asthenia, Blood thyroid stimulating hormone, C-reactive protein
Clinical narrative: First symptoms within two weeks were weakness in shoulders and itching eyes. Evolved within days into anxiety and high blood pressure, inability to sleep and fast hard heart rate. Continuous fast, heavy heart rate and high blood pressure. Extreme anxiety and loud heart beat in ears. Inability to regulate body temperature.  Extreme fatigue and unable to maintain walking at worse. Until medication was prescribed, beta blockers  was almost unable to sleep at all. Testing showed hypothyroid levels changing to hyperthyroid.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Eye pruritus, Fatigue, Full blood count, Gait inability
Clinical narrative: First symptoms within two weeks were weakness in shoulders and itching eyes. Evolved within days into anxiety and high blood pressure, inability to sleep and fast hard heart rate. Continuous fast, heavy heart rate and high blood pressure. Extreme anxiety and loud heart beat in ears. Inability to regulate body temperature.  Extreme fatigue and unable to maintain walking at worse. Until medication was prescribed, beta blockers  was almost unable to sleep at all. Testing showed hypothyroid levels changing to hyperthyroid.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Glycosylated haemoglobin, Heart rate increased, Hypertension, Hyperthyroidism, Insomnia
Clinical narrative: First symptoms within two weeks were weakness in shoulders and itching eyes. Evolved within days into anxiety and high blood pressure, inability to sleep and fast hard heart rate. Continuous fast, heavy heart rate and high blood pressure. Extreme anxiety and loud heart beat in ears. Inability to regulate body temperature.  Extreme fatigue and unable to maintain walking at worse. Until medication was prescribed, beta blockers  was almost unable to sleep at all. Testing showed hypothyroid levels changing to hyperthyroid.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lipids, Metabolic function test, Temperature regulation disorder, Thyroid mass, Thyroid stimulating immunoglobulin
Clinical narrative: First symptoms within two weeks were weakness in shoulders and itching eyes. Evolved within days into anxiety and high blood pressure, inability to sleep and fast hard heart rate. Continuous fast, heavy heart rate and high blood pressure. Extreme anxiety and loud heart beat in ears. Inability to regulate body temperature.  Extreme fatigue and unable to maintain walking at worse. Until medication was prescribed, beta blockers  was almost unable to sleep at all. Testing showed hypothyroid levels changing to hyperthyroid.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Thyroxine free, Tri-iodothyronine free, Ultrasound thyroid abnormal
Clinical narrative: First symptoms within two weeks were weakness in shoulders and itching eyes. Evolved within days into anxiety and high blood pressure, inability to sleep and fast hard heart rate. Continuous fast, heavy heart rate and high blood pressure. Extreme anxiety and loud heart beat in ears. Inability to regulate body temperature.  Extreme fatigue and unable to maintain walking at worse. Until medication was prescribed, beta blockers  was almost unable to sleep at all. Testing showed hypothyroid levels changing to hyperthyroid.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Vertigo
Clinical narrative: 12/24/2022 diagnosed with Covid, experienced vertigo. Medication prescribed were PAXLOVID and TESSALON. Also taking nexlosine.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Cardiac arrest, Dyspnoea, Fluid retention, Laboratory test, SARS-CoV-2 test negative
Clinical narrative: I received my 5th dose of Pfizer Bivalent booster on 10/06/2022. On 12/10/2022 I experienced Cardiac arrest. I was hospitalized for 5 days. I went to the urgent care at 03:00 PM first because I was experiencing shortness of breath and fluid retention. By 08:00 I was admitted in the hospital. At the hospital they did several test. They prescribed me with furosemide, LIPITOR and baby aspirin. I got out of the hospital on 12/17/2022.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received Moderna 0.5 mL IM x 1 as his first dose.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Vaccination error
Clinical narrative: Patient was given a pfizer pediatric 5-11 Covid vaccine. Patient was observed, no adverse reactions noted. MD was notified of vaccination error.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Exposure to communicable disease, Respiratory syncytial virus infection, Respiratory syncytial virus test positive
Clinical narrative: He did not have an adverse reaction to the vaccine. He did not show any symptoms prior to testing positive. He tested positive for COVID-19 and RSV on 11/25/2022. He had exposure to COVID-19 from his father and RSV from the day care he attends. We continued his daily regimen of using his inhaler, chest rubs and BENADRYL for his symptoms.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: He did not have an adverse reaction to the vaccine. He did not show any symptoms prior to testing positive. He tested positive for COVID-19 and RSV on 11/25/2022. He had exposure to COVID-19 from his father and RSV from the day care he attends. We continued his daily regimen of using his inhaler, chest rubs and BENADRYL for his symptoms.
Age: 79.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: No adverse event
Clinical narrative: No adverse outcome at this time.
Age: 43.0
Sex: M
Vaccine: HEPAB
Symptoms: Expired product administered, No adverse event
Clinical narrative: VACCINE EXPIRED 1/1/22. ADMINISTERED ON 1/6/22. NO HARM OR INJURY. NO ADVERSE EFFECT.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Ocular hyperaemia
Clinical narrative: Patient received Moderna 0.5 mL IM x 1. Patient's mother reported a cough and red eyes in the patient since that time.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Headache, Malaise, Pyrexia
Clinical narrative: On 12/23/2022, I had symptoms with sneezing and runny nose and within 12 hours, I started running a fever and headache. I took a test and was positive from 12/24/2022 until 1/2/2023. I had fever for 72 hours and was very fatigued and runny nose. I had a telehealth visit on 12/24/2022 and could not get PAXLOVID due to the holiday. I was improving by day 4 so they did not prescribe when I returned from holiday. I still have some sneezing and other mild symptoms but better.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: On 12/23/2022, I had symptoms with sneezing and runny nose and within 12 hours, I started running a fever and headache. I took a test and was positive from 12/24/2022 until 1/2/2023. I had fever for 72 hours and was very fatigued and runny nose. I had a telehealth visit on 12/24/2022 and could not get PAXLOVID due to the holiday. I was improving by day 4 so they did not prescribe when I returned from holiday. I still have some sneezing and other mild symptoms but better.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered, Vaccination error
Clinical narrative: The patient should have been administered Pfizer Bivalent Covid Vaccine and the nurse administered Regular Pfizer Covid Vaccine in error.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: The patient has not had any adverse effects that are known. The nurse administered regular Pfizer Covid 19 vaccine dose in error where the Pfizer Bivalent COVID 19 Vaccine should have been given.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered, Product administration error
Clinical narrative: The nurse administered Regular Pfizer Covid vaccine in error. The patient should have received the Pfizer Bivalent Covid Vaccine.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error, Underdose
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The patient has not had any adverse effects that are known. The nurse administered regular Pfizer Covid 19 vaccine dose in error where the Pfizer Bivalent COVID 19 Vaccine should have been given.
Age: 1.25
Sex: F
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: Pt was given expired diluent with the vaccine. The actual vaccine was not expired, only the diluent.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Condition aggravated, Cough, Fatigue
Clinical narrative: I had a slight fever, cough, chills, and body ache. I tested positive for COVID-19 and my doctor prescribed me PAXLOVID. I tested negative around 5 days after taking PAXLOVID. A couple days later I tested positive again for COVID-19. I had fatigue, chills, coughing, and body aches. I tested positive for COVID-19 for 8 days. My kidney disease is also acting up and my feet and hands are swollen. I have to go to the doctor for a check up.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pain, Peripheral swelling, Pyrexia, Renal disorder, SARS-CoV-2 test positive
Clinical narrative: I had a slight fever, cough, chills, and body ache. I tested positive for COVID-19 and my doctor prescribed me PAXLOVID. I tested negative around 5 days after taking PAXLOVID. A couple days later I tested positive again for COVID-19. I had fatigue, chills, coughing, and body aches. I tested positive for COVID-19 for 8 days. My kidney disease is also acting up and my feet and hands are swollen. I have to go to the doctor for a check up.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The patient should have been administered Pfizer Bivalent Covid Vaccine and the nurse administered Regular Pfizer Covid Vaccine in error.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The nurse administered Regular Pfizer Covid vaccine in error. The patient should have received the Pfizer Bivalent Covid Vaccine.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID: runny nose, slight headache
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute left ventricular failure, Acute respiratory failure, Ammonia increased, Asthma
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood thyroid stimulating hormone normal, Brain natriuretic peptide increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic left ventricular failure, Computerised tomogram head abnormal, Cough, Diabetic diet, Dyspnoea
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ejection fraction normal, Fatigue, Hepatic encephalopathy, Hypertrophic cardiomyopathy, Limb injury
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Myocardial ischaemia, Nasopharyngitis, Pleural effusion, Positive airway pressure therapy
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Pulmonary congestion, Pulmonary hypertension, Respiratory failure, Respiratory tract congestion
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Skin ulcer, Treatment noncompliance, Troponin increased, Wound treatment
Clinical narrative: Assessment and Plan Patient is a 70 y.o. female patient of CNP with history of atrial fibrillation, diabetes mellitus, chronic diastolic heart failure, HOCM, nonsustained V. tach, status post ICD device, OSA on CPAP, who presented to the emergency room with altered mental status, congestion, shortness of breath, cough, phlegm production.   Acute hepatic encephalopathy-resolved CT head-non acute (prior ischemic dx) On BiPAP with improvement Hold home gabapentin TSH-4.66 (mild elevation) Ammonia level 99>68 Patient admits she is not taking her lactulose regularly DC home today, patient informed to take lactulose to prevent recurrence   Acute on chronic hypoxemic hypercarbic respiratory failure-resolved Asthma with exacerbation-resolved OSA Start the patient albuterol MDI, Symbicort, dexamethasone BiPAP as above if needed She is on 3L of nasal cannula at baseline in addition to CPAP nightly   Acute on chronic diastolic heart failure Moderate pulmonary hypertension Hypertrophic cardiomyopathy Ejection fraction 60 to 65% BNP of 2700 Patient on Bumex 4 mg twice daily at home Continue metolazone and spironolactone Stop Bumex per nephrology and monitor for now   Covid-19 Virus Infection Date of onset of symptoms: 12/22/22 Symptoms present on admission: Shortness of breath, cough cold, congestion Date of covid positive test: 12/23/22 Vaccination status: vaccinated Imaging: Chest x-ray personally reviewed, bilateral pulmonary venous congestion, mild left pleural effusion Oxygen requirements on admission: 3L Current oxygen requirements: 3L Medical therapy: steroids Consultants following: ID Anticipated special isolation end date: 1/2/22   AKI on CKD III Creatinine baseline around 2 Presenting creatinine 2.41 Bumex as above Increased to 3.1 on 12/25 Nephrology consulted- recs appreciated   Lower extremity wounds Mainly on left, right appears improved Consult wound care   Atrial fibrillation Nonsustained V. tach s/p ICD Coumadin, dosed by pharmacy   Elevated troponin demand ischemia, trend troponin every 3 hours Troponin of 86 and then 88   Diabetes mellitus Diabetic diet Edo consulted- recs appreciated Increase as needed while on steroids   Hyperthyroidism Continue home Levothyroxine  TSH 4.66   Lower extremity Ulcer Follows with Podiatry outpatient Continue dressings left leg Xeroform, 4x4, kerlix, ace wrap and right leg kerlix with ace wrap    Morbid obesity due to excess calories BMI 44 Encouraged on lifestyle modification   GERD Continue daily PPI   Chronic fatigue PT/OT eval and treat